Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
Not Confirmed
Not Confirmed
24-25 July, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Not Confirmed
Not Confirmed
24-27 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
Industry Trade Show
Not Confirmed
24-25 July, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Industry Trade Show
Not Confirmed
24-27 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
25 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250625166139/en/Kashiv-BioSciences-Announces-Positive-Topline-Results-from-Confirmatory-Efficacy-Study-of-ADL-018-Biosimilar-Candidate-to-XOLAIR-omalizumab
25 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/25/3104830/0/en/Positive-Top-Line-Results-from-Confirmatory-Efficacy-Study-for-Proposed-Biosimilar-to-Xolair-omalizumab.html
29 Apr 2025
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761082
23 Apr 2025
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761084
07 Apr 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250403907363/en/Kashiv-BioSciences-Secures-%24150-Million-Debt-Financing-from-GoldenTree-Asset-Management
26 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/26/3049371/0/en/UK-Medicines-and-Healthcare-Products-Regulatory-Agency-Confirms-Acceptance-of-Marketing-Authorization-Application-for-Proposed-Biosimilar-to-Xolair-omalizumab.html
ABOUT THIS PAGE